EP Patent

EP2464633A1 — Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives

Assigned to Boehringer Ingelheim International GmbH · Expires 2012-06-20 · 14y expired

What this patent protects

The present invention relates to a method of making pyrimidines of formula (III) said method comprising reacting a compound of formula (I) with an oxygen, sulfur or nitrogen nucleophile of formula T-H; and reacting the compound obtained with an amine of formula (Il) [HN(R1 )R2] t…

USPTO Abstract

The present invention relates to a method of making pyrimidines of formula (III) said method comprising reacting a compound of formula (I) with an oxygen, sulfur or nitrogen nucleophile of formula T-H; and reacting the compound obtained with an amine of formula (Il) [HN(R1 )R2] to form a compound of formula (III) wherein X1, X2, T, R1 and R2 have the meanings as defined herein.

Drugs covered by this patent

Patent Metadata

Patent number
EP2464633A1
Jurisdiction
EP
Classification
Expires
2012-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.